A semiconducting polymer nano-prodrug for hypoxia-activated synergetic photodynamic cancer therapy

Photodynamic therapy (PDT) holds great promise for cancer therapy; however, its efficacy is often compromised by tumor hypoxia. Herein, we report the synthesis of a semiconducting polymer nanoprodrug (SPNpd) that not only efficiently generates singlet oxygen (1O2) under NIR photoirradiation but also...

Full description

Saved in:
Bibliographic Details
Main Authors: Cui, Dong, Huang, Jiaguo, Zhen, Xu, Li, Jingchao, Jiang, Yuyan, Pu, Kanyi
Other Authors: School of Chemical and Biomedical Engineering
Format: Article
Language:English
Published: 2019
Subjects:
Online Access:https://hdl.handle.net/10356/83296
http://hdl.handle.net/10220/50100
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-83296
record_format dspace
spelling sg-ntu-dr.10356-832962023-12-29T06:53:11Z A semiconducting polymer nano-prodrug for hypoxia-activated synergetic photodynamic cancer therapy Cui, Dong Huang, Jiaguo Zhen, Xu Li, Jingchao Jiang, Yuyan Pu, Kanyi School of Chemical and Biomedical Engineering Photodynamic Therapy Cancer Therapy Engineering::Chemical engineering Photodynamic therapy (PDT) holds great promise for cancer therapy; however, its efficacy is often compromised by tumor hypoxia. Herein, we report the synthesis of a semiconducting polymer nanoprodrug (SPNpd) that not only efficiently generates singlet oxygen (1O2) under NIR photoirradiation but also specifically activates its chemotherapeutic action in hypoxic tumor microenvironment. SPNpd is selfassembled from a amphiphilic polymer brush, which comprises a light-responsive photodynamic backbone grafted with poly(ethylene glycol) and conjugated with a chemodrug through hypoxia-cleavable linkers. The well-defined and compact nanostructure of SPNpd (30 nm) enables accumulation in the tumor of living mice. Owing to these features, SPNpd exerts synergistic photodynamic and chemo-therapy, and effectively inhibits tumor growth in a xenograft tumor mouse model. This study represents the first hypoxia-activatable phototherapeutic polymeric prodrug system with a high potential for cancer therapy. MOE (Min. of Education, S’pore) Accepted version 2019-10-08T06:14:24Z 2019-12-06T15:19:28Z 2019-10-08T06:14:24Z 2019-12-06T15:19:28Z 2019 2019 Journal Article Cui, D., Huang, J., Zhen, X., Li, J., Jiang, Y., & Pu, K. (2019). A semiconducting polymer nano‐prodrug for hypoxia‐activated photodynamic cancer therapy. Angewandte Chemie, 131(18), 5981-5985. doi:10.1002/ange.201814730 1433-7851 https://hdl.handle.net/10356/83296 http://hdl.handle.net/10220/50100 10.1002/ange.201814730 214922 en Angewandte Chemie International Edition This is the peer reviewed version of the following article: Cui, D., Huang, J., Zhen, X., Li, J., Jiang, Y., & Pu, K. (2019). A semiconducting polymer nano‐prodrug for hypoxia‐activated photodynamic cancer therapy. Angewandte Chemie, 131(18), 5981-5985, which has been published in final form at https://doi.org/10.1002/ange.201814730. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. 5 p. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Photodynamic Therapy
Cancer Therapy
Engineering::Chemical engineering
spellingShingle Photodynamic Therapy
Cancer Therapy
Engineering::Chemical engineering
Cui, Dong
Huang, Jiaguo
Zhen, Xu
Li, Jingchao
Jiang, Yuyan
Pu, Kanyi
A semiconducting polymer nano-prodrug for hypoxia-activated synergetic photodynamic cancer therapy
description Photodynamic therapy (PDT) holds great promise for cancer therapy; however, its efficacy is often compromised by tumor hypoxia. Herein, we report the synthesis of a semiconducting polymer nanoprodrug (SPNpd) that not only efficiently generates singlet oxygen (1O2) under NIR photoirradiation but also specifically activates its chemotherapeutic action in hypoxic tumor microenvironment. SPNpd is selfassembled from a amphiphilic polymer brush, which comprises a light-responsive photodynamic backbone grafted with poly(ethylene glycol) and conjugated with a chemodrug through hypoxia-cleavable linkers. The well-defined and compact nanostructure of SPNpd (30 nm) enables accumulation in the tumor of living mice. Owing to these features, SPNpd exerts synergistic photodynamic and chemo-therapy, and effectively inhibits tumor growth in a xenograft tumor mouse model. This study represents the first hypoxia-activatable phototherapeutic polymeric prodrug system with a high potential for cancer therapy.
author2 School of Chemical and Biomedical Engineering
author_facet School of Chemical and Biomedical Engineering
Cui, Dong
Huang, Jiaguo
Zhen, Xu
Li, Jingchao
Jiang, Yuyan
Pu, Kanyi
format Article
author Cui, Dong
Huang, Jiaguo
Zhen, Xu
Li, Jingchao
Jiang, Yuyan
Pu, Kanyi
author_sort Cui, Dong
title A semiconducting polymer nano-prodrug for hypoxia-activated synergetic photodynamic cancer therapy
title_short A semiconducting polymer nano-prodrug for hypoxia-activated synergetic photodynamic cancer therapy
title_full A semiconducting polymer nano-prodrug for hypoxia-activated synergetic photodynamic cancer therapy
title_fullStr A semiconducting polymer nano-prodrug for hypoxia-activated synergetic photodynamic cancer therapy
title_full_unstemmed A semiconducting polymer nano-prodrug for hypoxia-activated synergetic photodynamic cancer therapy
title_sort semiconducting polymer nano-prodrug for hypoxia-activated synergetic photodynamic cancer therapy
publishDate 2019
url https://hdl.handle.net/10356/83296
http://hdl.handle.net/10220/50100
_version_ 1787136793971261440